Saturday, April 28, 2018 10:12:09 AM
LFIN ,BITCF,TRTCD - was NEVER, NEVER - on FAST TRUCK from FDA ! (80% drugs from FDA FAST TRUCK - APROOVED !!! - Fact History )
NICE TRY..... Now I’m saying YOU SHORTED GERN , and losing a lot $$$$$$$. Your opinion Full scam ....
You said - (Every biotech company does puts their pipeline drugs on its website. Nothing to read into. ) ??? What is it ?
http://www.geron.com/r-d/pipeline/
https://globaltrialfinder.janssen.com/trial/CR107947
https://clinicaltrials.gov/ct2/history/NCT02426086?A=25&B=26&C=merged#StudyPageTop
Enjoy this information , but your time is gone . Yes, history repeat your short position will be burn , like NOK on sweet September 3 2013 .
P.s. While a buyout would be a great for Geron investors, there are many other catalysts besides a buyout that could cause the share price to jump. JNJ is currently slated to issue a continuation decision by Q3 of this year. In addition, the positive string of FDA decisions for Imetelstat (Orphan Drug designation and Fast Track status) and the promising preliminary clinical results that were announced in March 2018 are giving investors hope that Accelerated Approval or Break Through Designation might occur in the near future. Either of these events will likely cause the share price to spike and head north of $10 even without a buyout occurring.
NICE TRY..... Now I’m saying YOU SHORTED GERN , and losing a lot $$$$$$$. Your opinion Full scam ....
You said - (Every biotech company does puts their pipeline drugs on its website. Nothing to read into. ) ??? What is it ?
http://www.geron.com/r-d/pipeline/
https://globaltrialfinder.janssen.com/trial/CR107947
https://clinicaltrials.gov/ct2/history/NCT02426086?A=25&B=26&C=merged#StudyPageTop
Enjoy this information , but your time is gone . Yes, history repeat your short position will be burn , like NOK on sweet September 3 2013 .
P.s. While a buyout would be a great for Geron investors, there are many other catalysts besides a buyout that could cause the share price to jump. JNJ is currently slated to issue a continuation decision by Q3 of this year. In addition, the positive string of FDA decisions for Imetelstat (Orphan Drug designation and Fast Track status) and the promising preliminary clinical results that were announced in March 2018 are giving investors hope that Accelerated Approval or Break Through Designation might occur in the near future. Either of these events will likely cause the share price to spike and head north of $10 even without a buyout occurring.
Recent GERN News
- Geron Plans to Announce First Quarter 2026 Financial Results on May 6, 2026 • GlobeNewswire Inc. • 04/22/2026 11:00:00 AM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/20/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/15/2026 12:14:14 AM
- Geron Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/14/2026 08:05:00 PM
- Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary • GlobeNewswire Inc. • 04/13/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/07/2026 08:31:53 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/07/2026 08:31:07 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/07/2026 08:30:34 PM
- Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/06/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:30:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:37:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:33:13 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/26/2026 09:32:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 12:18:10 PM
- Geron Announces Appointment of New Members to its Board of Directors • GlobeNewswire Inc. • 03/26/2026 12:00:00 PM
- Geron Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 03/18/2026 08:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/03/2026 09:30:02 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/02/2026 12:47:55 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 12:11:02 PM
- Geron shares drop after Q4 results miss estimates despite Rytelo growth • IH Market News • 02/25/2026 03:39:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:15:13 PM
- Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- Geron Plans to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 11:11:23 PM
